Search Results - "Nankivell, M."

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study by Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.

“…Oesophageal (OeC) and gastric (GC) cancer patients are treated with similar multimodal therapy and have poor survival. There remains an urgent clinical need to…”
Get full text

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial by Smyth, E.C., Nyamundanda, G., Cunningham, D., Fontana, E., Ragulan, C., Tan, I.B., Lin, S.J., Wotherspoon, A., Nankivell, M., Fassan, M., Lampis, A., Hahne, J.C., Davies, A.R., Lagergren, J., Gossage, J.A., Maisey, N., Green, M., Zylstra, J.L., Allum, W.H., Langley, R.E., Tan, P., Valeri, N., Sadanandam, A.

“…Following neoadjuvant chemotherapy for operable gastroesophageal cancer, lymph node metastasis is the only validated prognostic variable; however, within lymph…”
Get full text

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design by Gilbert, D C, Nankivell, M, Rush, H, Clarke, N W, Mangar, S, Al-Hasso, A, Rosen, S, Kockelbergh, R, Sundaram, S K, Dixit, S, Laniado, M, McPhail, N, Shaheen, A, Brown, S, Gale, J, Deighan, J, Marshall, J, Duong, T, Macnair, A, Griffiths, A, Amos, C L, Sydes, M R, James, N D, Parmar, M K B, Langley, R E

“…Androgen deprivation therapy (ADT), usually achieved with luteinising hormone releasing hormone analogues (LHRHa), is central to prostate cancer management…”
Get full text

Interim Data from the Medical Research Council QUARTZ Trial: Does Whole Brain Radiotherapy Affect the Survival and Quality of Life of Patients with Brain Metastases from Non-small Cell Lung Cancer? by Langley, R.E, Stephens, R.J, Nankivell, M, Pugh, C, Moore, B, Navani, N, Wilson, P, Faivre-Finn, C, Barton, R, Parmar, M.K.B, Mulvenna, P.M

“…Abstract Aims Over 30% of patients with non-small cell lung cancer (NSCLC) develop brain metastases. If inoperable, optimal supportive care (OSC), including…”
Get full text

Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy by Davidson, M., Nankivell, M., Cunningham, D., Starling, N., Koh, D.-M., Brown, G., Allum, W., Wotherspoon, A., Smyth, E., Ly, L., Kleovoulou, N., Langley, R., Riddell, A.

Get full text

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer by Lee, C.K., Simes, R.J., Brown, C., Gebski, V., Pfisterer, J., Swart, A.-M., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Schauer, C., Pisano, C., Parma, G., Baumann, K., Ledermann, J.A., Pujade-Lauraine, E., Bentley, J., Kristensen, G., Belau, A., Nankivell, M., Canzler, U., Lord, S.J., Kurzeder, C., Friedlander, M.

“…Patients with platinum-sensitive recurrent ovarian cancer have variable prognosis and survival. We extend previous work on prediction of progression-free…”
Get full text

165 Quality of life after treatment for brain metastases from NSCLC: An update on the Medical Research Council QUARTZ trial by Mulvenna, P, Nankivell, M, Gopalakrishnan, G, Langley, R

Get full text

Interim results in clinical trials: Do we need to keep all interim randomised clinical trial results confidential? by Stephens, R.J, Langley, R.E, Mulvenna, P, Nankivell, M, Vail, A, Parmar, M.K.B

“…Abstract Objectives Guidelines for the conduct of clinical trials emphasize the importance of keeping the interim results from the main endpoints confidential,…”
Get full text

162 Quality of life after treatment for inoperable brain metastases from non-small cell lung cancer: An update on the Medical Research Council QUARTZ randomised clinical trial by Mulvenna, P, Barton, R, Wilson, P, Faivre-Finn, C, Gopalakrishnan, G.S, Nankivell, M, Langley, R.E

Get full text

188: Quality of life after treatment for brain metastases: final demographic data from the QUARTZ trial by Mulvenna, P, Nankivell, M, Barton, R, Wilson, P, Faivre-Finn, C, Stephens, R, Ardron, D, McColl, E, Moore, B, Brisbane, I, Sydes, B, Langley, R

Get full text

The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit by Wheatley-Price, P., Ma, C., Ashcroft, L.F., Nankivell, M., Stephens, R.J., White, S.C., Lorigan, P., Thatcher, N., Blackhall, F.H., Shepherd, F.A.

“…Previous studies reported that women survive longer than men, but experience greater toxicity, when treated for small-cell lung cancer (SCLC). Individual…”
Get full text

101 Incidental discovery is the prevalent referral pathway to surgery for early stage lung cancer by Brazil, S.V, Brown, J.M, McAsey, D, Nankivell, M, Lawrence, D.R, George, J.P, Janes, S.M, Navani, N

Get full text

159 Quality of life after treatment for brain metastases: An update on the QUARTZ trial – one year on from an interim data release by Mulvenna, P, Barton, R, Wilson, P, Faivre-Finn, C, Pugh, C, Nankivell, M, Langley, R

Get full text

Quality of Life in the ICON7 GCIG Phase III Randomised Clinical Trial by Stark, D, Nankivell, M, Hilpert, F, Elit, L, Brown, J, Lanceley, A, Valikova, G, Oza, A, Swart, A.M, Perren, T

Get full text

9070 POSTER Whole Brain Radiotherapy for Inoperable Brain Metastases From Non-small Cell Lung Cancer – Individual Versus Community Uncertainty by Faivre-Finn, C, Mulvenna, P, Barton, R, Wilson, P, Pugh, C, Nankivell, M, Langley, R

Get full text

Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial by Navani, N, Nankivell, M, Stephens, R J, Parmar, M K B, Gilligan, D, Nicolson, M, Groen, H J M, van Meerbeeck, J P

Get more information

110 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part one, baseline characteristics, survival and QALYs by Mulvenna, P, Barton, R, Faivre-Finn, C, Wilson, P, Langley, R, Pugh, C, Nankivell, M

Get full text

111 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part two, symptoms, quality of life and data completion by Mulvenna, P, Barton, R, Faivre-Finn, C, Wilson, P, Langley, R, Pugh, C, Nankivell, M

Get full text

Survival of Patients with Non-small Cell Lung Cancer and Brain Metastases by Mulvenna, P, Barton, R, Wilson, P, Faivre-Finn, C, Nankivell, M, Stephens, R, Langley, R, Moore, B, Ardron, D

Get full text

Inaccurate clinical nodal staging of non-small cell lung cancer: Evidence from the MRC LU22 multi-centre randomised trial by Navani, N, Nankivell, M, Stephens, R.J, Parmar, M.K.B, Gilligan, D, Nicolson, M, Groen, H.J.M, van Meerbeeck, J.P

Get full text